Mess in a Bottle CEO Kalilah Wright explains why she walked away from a six-figure job in architecture to launch her own brand.
In her first match since September, former U.S. Open finalist Madison Keys beat Belinda Bencic 6-4, 6-1 at the Qatar Open on Tuesday. Keys hit 24 winners against 13 for the sixth-seeded Bencic, who was coming off a loss to Iga Swiatek in the final of the Adelaide International on Saturday. Keys was playing for the first time since her first-round exit at the French Open.
President Joe Biden's nominee to run the federal consumer watchdog agency is likely to be face hostile questioning from Republican Senators on Tuesday, but is likely to be confirmed with Democrats controlling a majority in the Senate. Rohit Chopra, currently a Democratic commissioner on the Federal Trade Commission, would be the third permanent director of the relatively new agency. President Donald Trump's director of Consumer Financial Protection Bureau, Kathy Kraninger, was asked to resign by President Biden on the first day of his term.
The "Major Players in China Hydrogen Industry" report has been added to ResearchAndMarkets.com's offering.
Tachyum Delivers First Software Emulation Systems- HPC applications, convolutional AI, explainable AI, general AI, bio AI, and spiking neural networks
Sometimes, you just need a second chance. Fred Zinkie identifies some key post-hype sleepers to consider in fantasy baseball drafts.
LEAD PLAINTIFF DEADLINE IS APRIL 13, 2021NEW YORK, March 02, 2021 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed has been filed in the United States District Court for the Eastern District of New York against bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired bluebird securities between May 11, 2020 and November 4, 2020, both dates inclusive (the "Class Period"). All investors who purchased shares of bluebird bio, Inc. and incurred losses are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action or join the case on our website, www.whafh.com. If you have incurred losses in the shares of bluebird bio, Inc., you may, no later than April 13, 2021, request that the Court appoint you lead plaintiff of the proposed class. Please contact Wolf Haldenstein to learn more about your rights as an investor in the shares of bluebird bio, Inc. CLICK HERE TO JOIN CASE The filed complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose to investors that: data supporting bluebird's BLA submission for LentiGlobin for SCD was insufficient to demonstrate drug product comparability; Defendants downplayed the foreseeable impact of disruptions related to the COVID-19 pandemic on the Company's BLA submission schedule for LentiGlobin for SCD, particularly with respect to manufacturing; as a result of all the foregoing, it was foreseeable that the Company would not submit the BLA for LentiGlobin for SCD in the second half of 2021; and as a result, the Company's public statements were materially false and misleading at all relevant times. The price of Company shares dropped as much as 35% on February 16, 2020 intraday after the company announced the suspension of its Phase 1/2 and Phase 3 studies of its sickle cell therapy candidate.The company suspended the studies due to a reported Suspected Unexpected Serious Adverse Reaction (SUSAR) of acute myeloid leukemia (AML). Bluebird placed the study on hold after receiving a report last week that a patient who was treated more than five years ago in a study was diagnosed with AML. Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation. If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com. Contact: Wolf Haldenstein Adler Freeman & Herz LLP Kevin Cooper, Esq.Gregory Stone, Director of Case and Financial AnalysisEmail: gstone@whafh.com, kcooper@whafh.com or classmember@whafh.comTel: (800) 575-0735 or (212) 545-4774 This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Dr. Seuss Enterprises announced this morning that they will stop publishing six of Dr. Seuss’ picture books amid accusations of racist imagery. The company that seeks to preserve and protect the author’s works released a statement explaining that these six books portray people in ways that are hurtful and wrong. The titles being discontinued include […]
The R&B superstar yearned to appear on the TV talent show of his youth, and the outcome was less than legendary.
AMA Houston Gives Back grant applications are now being accepted through April 23, 2021.
Minneapolis was planning to pay social media influencers to post "city-approved" messages.
"A weight loss post? It almost undoes all the positivity that comes from this."
The tennis star and her three-year-old daughter are featured in Stuart Weitzman's spring campaign.
DunhamTrimmer, the Global Leader in Business Intelligence for the global Biocontrols and Biostimulants industries, has announced a May 1, 2021 release date for its much anticipated Global Pheromones Market Report. The new report features a partnership with world-renowned pheromones expert and lead author Dr. Owen Jones and is designed to be an authoritative, "view-from-the-inside" resource for existing players as well as companies and investors seeking to capitalize on the booming pheromones industry.
Charles & Colvard, Ltd. (Nasdaq: CTHR or the "Company"), a globally recognized lab created gemstone company specializing in fine jewelry, announced that Don O'Connell, President and CEO, and Clint J. Pete, Chief Financial Officer, will present at the virtual 33rd Annual ROTH Conference, taking place March 15-17, 2021.
Hyperion Materials & Technologies today announced that Robert L. Wood has joined the company's Board of Directors, effective immediately.
(Bloomberg) -- Tunisia should explain the country’s fragile economic situation to its people and ensure they support any planned reforms before discussing a new program with the International Monetary Fund, a fund official said.A key priority for the government will be to devise a mechanism to deal with mounting debts on the part of state-owned entities - dues which account for about 40% of the gross domestic product, the fund’s mission chief to the North African nation, Chris Geiregat, said Tuesday in a press briefing.“Before we adopt a new program with the IMF, it will be important for authorities to start explaining to the population the severity and fragility of the situation,” he said, stressing that the government must include all “stakeholders” in the discussions. The longer it takes authorities to reach “social consensus” on the reforms, the more difficult the situation will become, Geiregat said.IMF Urges Tunisia to Lower Wage Bill, Limit Energy SubsidiesTo break with the “tepid performance of the past,” Tunisia will need deep structural reforms, but this time authorities must ensure these are “strongly implemented” and not just adopted, he said.“We have made it clear that if we see a clear reform program” that benefited from a national dialogue, “then we will support you,” Geiregat said.Geiregat also said:Tunisia central bank needs to be vigilant about stability of banking sector, because impact of coronavirus hasn’t fully surfaced in banking sectorCentral bank needs to also devise plan for post-Covid recovery for the sector(Corrects to show IMF is not asking Tunisia to enact reforms before a program approved; clarifies quote in fourth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
EXCLUSIVE: The Remake Co, FilmSharks’ specialty label handling remake rights, has closed a deal with Korea’s Covenant Pictures for rights to the Argentinian feature Crazy Heart. Directed by Marcos Carnevale (Inseparable), the Spanish-language comedy stars Adrian Suar (A Boyfriend for My Wife) as Fernando. Fernando doesn’t have that one special love of his life. He […]
Portugal had its fewest COVID-19 patients in hospital in four months on Tuesday, data showed, as its prime minister warned that enforcing lockdown curbs remained essential in a country that topped global death rates a month ago. For several weeks in January, Portugal's health service stood on the brink of collapse as it recorded the world's worst surge in coronavirus infections and fatalities per capita. But a nationwide lockdown put in place on Jan. 15 has rapidly brought those figures down, and the 38 deaths and 691 new cases recorded on Tuesday were back on a par with averages logged in October, when businesses were still open.
According to Ofgem, the sectors biggest suppliers made mistakes, including Ovo Energy, Shell, British Gas, E.On, EDF, Npower, Scottish Power, SSE and Octopus.
The MolinaCares Accord donates $273,000 to Nevada nonprofits combating health disparities
Yahoo Home